Jeantet advises Sartorius Stedim Biotech on the acquisition of Novasep’s chromatography process equipment division
Paris, 6 January 2021 – Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today announced it has entered into an agreement to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained.
Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA, China and India. The proposed transaction is subject to antitrust approvals and the information and consultation of Novasep’s works council and is expected to close during the first half of 2021.
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2019, the company employed approx. 6,200 people, and earned sales revenue of 1,440.6 million euros.
Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep’s unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients, as well as fermentation and chemical commodities industries.
Sartorius Stedim Biotech was advised by Jeantet with a team lead by Karl Hepp de Sevelinges (partner, Corporate/M&A), including Michael Samol (counsel, Corporate/M&A), Robert d’Orglandes (associate, Corporate/M&A), Laetitia Ternisien (counsel, Employment) and Gabriel di Chiara (counsel, Tax).
The firm Milbank LLP has worked closely with Jeantet, notably with Michael Bernhardt (partner, Corporate/M&A) and Alexander Rinne (partner, Antitrust), as well as the firm GvW Graf von Westphalen for Chinese law aspects.
Novasep was advised by White & Case LLP with a team lead by François Leloup (partner, Corporate/M&A), including Delphin Boucher (counsel, Corporate/M&A), Alexandre Jaurett (partner, Employment) and Orion Berg (counsel, Regulatory). Teams in the New-York and Washington offices have been involved on US law aspects and a team in the Shanghai office has been involved on Chinese law aspects.
Jeantet advises QUADPACK on its acquisition by PSB INDUSTRIES
Paris, 21 November, 2024 – Jeantet is advising the listed company Quadpack Industries on its acquisition by PSB Industries, both specialized in the development, manufacture and distribution of packaging for the cosmetics industry, for approximately EUR 140 million. Quadpack Industries, a Catalan-based company listed on Euronext Growth Paris, and PSB Industries (the parent of the […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised WEINBERG CAPITAL PARTNERS in its investment in MARCEL VILLETTE GROUP, a specialist in landscaping and green space maintenance
Paris, 5 November, 2024 – Jeantet advised Weinberg Capital Partner’s WCP Impact Dev #1 in the context of the carve-out of the Marcel Villette Group, a leading player in the maintenance and creation of green spaces in Ile-de-France, in partnership with its CEO, Armand Joyeux and key executives. Founded in 1929 by Marcel Villette, the […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises JIN in its acquisition of LJ COMMUNICATION
Paris, October 21 2024 – Jeantet has advised JIN, an independent public relations group, in its acquisition of LJ Communication, a consulting agency specialising in communications, public relations, media and influence in the health and environment sectors. Founded in 2000, LJ Communication is a Paris-based public relations consultancy specialising in the healthcare sector. It joins […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | LISTED COMPANIES AND CAPITAL MARKETS LAW
Jeantet advises ADVANTECH CO. LTD, on the acquisition of a block of shares, prior to the filing of a draft mandatory tender offer for the remaining shares of AURES TECHNOLOGIES
Paris, October 15 2024 – Jeantet has advised the Taiwanese group Advantech Co., Ltd., a global leader in the Internet of Things (“IoT”) intelligent systems sector and listed on the Taiwan Stock Exchange, on the off-market acquisition of a block of shares representing 35.76% of the share capital of Aures Technologies SA from its founder […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advises BOSSARD group on the acquisition of AERO NEGOCE INTERNATIONAL group
Paris, July 24, 2024 – Jeantet has advised the Swiss Bossard Group, a leading global provider of product solutions and services in the field of industrial fastening and assembly technology listed on SIX Swiss Exchange (BOSN), in the signing of an agreement for the acquisition of the French group Aero Negoce International (ANI). Aero Negoce […]
| CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises GROUPE ELIOR in its acquisition of DEMOULIN TRAITEUR
Paris, 19 July, 2024 – Jeantet has advised the Elior group, one of the world’s leading contract caterers, on its acquisition of Démoulin Traiteur, a high-end catering services company. Growing rapidly since its creation in 1991 and its takeover by the Derichebourg group in 2023, Elior, a publicly listed French group specializing in contract catering, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised IST on the sale of three wind farm projects in France
Paris, 9 July, 2024 – Jeantet advised IST, a Swiss independent investment foundation, on the sale of three wind farm projects to Volta group. Jeantet assisted IST in the sale to the French Volta group (an independent developer and producer of renewable energy) of three wind farms in France with a combined total capacity of […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised IQEQ MANAGEMENT on the implementation of a trust solution (Fiducie-Gestion) by CARMAT in accordance with its agreement entered into with all its financial creditors, including the european investment bank, on new repayment terms for its bank loans
Paris, on June 21 2024 – Jeantet advised IQEQ Management, an AMF-accredited management company, as trustee, in connection with the implementation of a trust solution (fiducie-gestion) by Carmat, in accordance with the final agreement entered into on March 22, 2024 with its financial creditors, including the European Investment Bank, on new repayment terms for its […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advised ANANDA IMPACT VENTURES and CONTRARIAN VENTURES on the EUR 3.6 million SSED round of DECADE ENERGY
Jeantet advised Ananda Impact Ventures and Contrarian Ventures on the EUR 3.6 million seed round of Decade Energy. Decade Energy is a French start-up providing logistics companies with holistic, reliable and cost-efficient solutions that enable the electrification of commercial electric vehicle fleets, aiming to the decarbonation of logistic fleets. The company is headquartered in Paris, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised PLENIUM PARTNERS and SWEN CAPITAL PARTNERS in the fundraising of €87 million of SMART ENERGIES to accelerate its development
Paris, 7 June, 2024 – Jeantet advised Plenium Partners’ and SWEN Capital Partners’ funds in their investment in Smart Energies, a French leading solar IPP, alongside the long-standing historical shareholders of Smart Energies, and RGREEN INVEST, which has supported the group since 2022. The capital increase amounts to €87 million and will accelerate the deployment […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises Pegase Healthcare in connection with its acquisition of the Com&Co Group
Paris, May 31, 2024 – Jeantet advised Pegase Healthcare, a strategy and communications consultancy firm that supports transformations in the healthcare sector, in LBO with Turenne Santé since 2022, on the acquisition of Com&Co, a Marseille-based player in medical training and conference organizer with sales of almost €10 million. This external growth will enable the […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises PULLUP ENTERTAINMENT in the context of its share capital increase without preferential subscription rights by way of a public offering and with a priority period, on an irreducible basis only, for its existing shareholders, for a total amount of circa €23 million
Paris, May 31, 2024 – Jeantet advised PulluP Entertainment, one of the European leaders in the publishing and development of video games iii – AA for PC and Consoles, in the context of its share capital increase without preferential subscription rights of the shareholders by way of a public offering and with a priority period, […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW